Labcor

What Labcor does

Labcor Laborat\u00f3rios Ltda. (operating as Labcor / Labcor Bi\u00f3pr\u00f3teses) is a Brazilian specialty medical device manufacturer founded in 1984 and headquartered in Contagem, Minas Gerais. The company develops, manufactures, and commercializes biological prostheses and surgical grafts \u2014 primarily heart valves, vascular grafts, pediatric cardiac products, and reconstructive membranes \u2014 for cardiovascular surgery, pediatric congenital heart surgery, and reconstructive urology. Its core technological differentiator is L-Hydro, a proprietary 100% aldehyde-free tissue preservation process that yields a non-cellular matrix enabling biointegration and in vivo tissue growth; complementary capabilities include the REDUCER calcium-mitigation treatment and comprehensive Post-Marketing Surveillance across Portuguese, Spanish, and English.

Labcor operates two go-to-market motions. First, it sells its own branded product portfolio directly to Brazilian hospitals and cardiac surgery centers via a direct sales and distributor network (with sales offices in Rio de Janeiro and S\u00e3o Paulo), and internationally through export distributors serving the Americas, Europe, and Asia. Second, it provides OEM contract manufacturing and biological tissue component supply to major global cardiovascular device developers, including Carmat (the AESON fully implantable artificial heart), TRiCares, Symetis, Cryolife, Thubrikar, Polares, InnovHeart, Carbomedics, inQB8, and Truleaf \u2014 functioning as a co-developer of next-generation TAVI, transcatheter, and artificial-heart products under ISO 13485:2016.

The company's operational infrastructure centers on the 2020-contaminated Contagem facility spanning over 3,000 m\u00b2 with 750 m\u00b2 of ISO 7 classified cleanroom, with monthly throughput exceeding 1,500 units and annual capacity of approximately 10,000 valves and grafts. Regulatory credentials include ANVISA CBPF (Brazilian Good Manufacturing Practices), ISO 13485:2016, and EDQM certification for bovine pericardium \u2014 collectively enabling both domestic Brazilian distribution and international market access. With 150,000+ implants performed worldwide over 40 years and a product portfolio spanning adult cardiac, pediatric cardiac, and urological reconstruction, Labcor occupies a defensible niche as a Latin American specialty tissue processor serving both end-user hospitals and the global cardiovascular OEM ecosystem.

Name

Labcor

Legal name

Labcor Laboratórios Ltda.

Website

https://labcor.com.br

Company type

Private

Founded year

1984

Operating status

Operating

Headcount range

101–250 employees

Short description

Labcor is a Brazilian manufacturer, founded in 1984, of biological heart valves, vascular grafts, and reconstructive membranes using proprietary aldehyde-free L-Hydro tissue preservation technology, serving cardiac surgery hospitals domestically and via OEM partnerships with global cardiovascular device developers internationally.

Ownership category

akta.pro rank

Product category

Cardiovascular Medical Devices

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (33911)

SIC

Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Cardiovascular & Vascular Regeneration (vascular grafts, angiogenesis) (HLAAAGAJ)

Keywords

• Biological cardiac prostheses
• Heart valve bioprostheses
• Tissue preservation technology
• Medical device OEM manufacturing
• Pediatric cardiac grafts

Headquarters

HQ city

Contagem

HQ country

Brazil

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Proprietary Medical Device Sales: Labcor develops, manufactures, and commercializes its own line of biological prostheses and surgical grafts (heart valves, vascular grafts, pediatric products, urological reconstructive products) under its own brand. Products are sold directly to hospitals and cardiac surgery centers domestically and through distributors internationally.
2. OEM Manufacturing Services: Labcor provides contract manufacturing and co-development services to other medical device companies, contributing to the development of new products from conception through prototyping and manufacturing, including regulatory, engineering, microbiological testing, and validations. Partners include Carmat, TRiCares, Symetis, Cryolife, Thubrikar, and others.
3. Licensing / Component Supply: Labcor supplies biological tissue components (bovine pericardium, porcine valves, etc.) to OEM partners who incorporate them into their own medical devices, functioning as a component supplier and technology licensor.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Labcor develops, manufactures, and commercializes biological prostheses and surgical grafts—including bovine pericardial and porcine heart valves, vascular and pediatric cardiac grafts, and reconstructive membranes—using its proprietary 100% aldehyde-free L-Hydro tissue preservation technology. The company also provides OEM contract manufacturing, co-development, and biological tissue component supply to major global medical device companies.

Product overview

Labcor develops and manufactures a comprehensive portfolio of biological prostheses and surgical grafts, organized into Adult and Pediatric lines. The Adult line includes cardiac valve prostheses (Dokimos® Plus Aórtica and Mitral, TLPB-A Supra Aórtica and TLPB-M Mitral), aortic grafts (Instar), bovine pericardial patches, reconstructive membranes (Vivendi L-Hydro®), coronary grafts (Corograft L-Hydro®), and tricuspid annuloplasty rings (STAR). The Pediatric line features pulmonary valved grafts (Velum L-Hydro®, Kyros), corrugated arterial grafts (T08), and monocuspid plates (Monocúspide JP). All products utilize tissue preservation technologies, with the proprietary aldehyde-free L-Hydro technology as a key differentiator across multiple product families.

Differentiator

Problem solved

Functional benefit

Brands

• L-Hydro: Exclusive aldehyde-free tissue preservation technology developed by Labcor for biological tissue implants.
• Vivendi L-Hydro
• Dokimos Plus
• Kyros
• Velum L-Hydro

Products and services

• Dokimos Plus Aórtica Bovine pericardial aortic heart valve bioprosthesis with calcium-mitigating REDUCER treatment and an outside-mounted design, used in adult aortic valve replacement surgery.
• Dokimos Plus Mitral Bovine pericardial mitral heart valve prosthesis for adult mitral valve replacement surgery.
• TLPB-A Supra Aórtica Porcine aortic heart valve with calcium-mitigating treatment, designed for supra-annular implantation in adult aortic valve replacement.
• TLPB-M Mitral Porcine mitral heart valve prosthesis for adult mitral valve replacement surgery.
• Instar Inorganic valved biological graft for aortic applications.
• Patch Bovine pericardial membrane used in surgical patching procedures for cardiac and vascular reconstruction.
• Vivendi L-Hydro Reconstructive membrane preserved with 100% aldehyde-free L-Hydro technology for tissue reconstruction, used in urological reconstructive procedures and duramater substitution.
• Corograft L-Hydro Coronary artery graft preserved with L-Hydro aldehyde-free technology for coronary artery bypass procedures.
• STAR Three-dimensional tricuspid annuloplasty ring anatomically configured to treat functional tricuspid insufficiency in adult cardiac surgery.
• Velum L-Hydro Pulmonary arterial tubular valved graft made of bovine pericardium with a porcine pulmonary valve, preserved with aldehyde-free L-Hydro technology for pediatric congenital heart defect corrections.
• T08 Corrugated arterial tubular valved graft composed of a porcine pericardial valve mounted in a corrugated bovine pericardial tube with glutaraldehyde treatment, used in pediatric cardiac surgery.
• Monocúspide JP Monocuspid plate made of glutaraldehyde-treated bovine pericardium for right ventricular outflow tract reconstruction in pediatric congenital heart surgeries.
• Kyros Pulmonary cardiac valve bioprosthesis made of bovine pericardium preserved with the exclusive aldehyde-free L-Hydro technology, designed with a low-profile for pediatric pulmonary valve replacement.
• OEM Contract Manufacturing Services Contract manufacturing, co-development, and biological tissue component supply services for global medical device companies, including regulatory, engineering, microbiological testing, and validation support under ISO 13485:2016 certification.

Quantifiable outcome

• Over 150,000 implants performed worldwide
• +3 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• Carmat SAcoreOEM/ Whitelabel/ Licensing PartnerLabcor is a partner and supplier to Carmat SA, the only company in the world manufacturing the AESON fully implantable artificial heart. Labcor supplies critical biological tissue components for this device, which provides mobility and autonomy to patients awaiting heart transplants.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• LifeNet Health: Non-profit tissue allograft and bioprocessing organization providing cardiovascular and orthopedic tissue products; comparable to Labcor in biological tissue processing capabilities for medical implants.
• LeMaitre Vascular: Specialty manufacturer of vascular grafts, patches, and carotid shunts — directly comparable to Labcor's Corograft, Vivendi L-Hydro, and Patch product lines in vascular reconstruction.
• Artivion (formerly CryoLife): U.S.-based cardiovascular tissue processing company specializing in preserved human and animal tissue allografts and heart valves — both a direct competitor in tissue-preserved valves and a current OEM partner of Labcor.
• Braile Biomédica: Brazilian manufacturer of cardiac surgery products including biological heart valves and oxygenators, headquartered in São José do Rio Preto and Labcor's most direct domestic competitor in the Brazilian market.

Broad incumbents

• Medtronic: Major manufacturer of surgical and transcatheter heart valves (Avalus, CoreValve/Evolut) with global hospital relationships that dwarf Labcor's sales footprint in adult cardiac surgery.
• Edwards Lifesciences: Global leader in tissue heart valves (PERIMOUNT, INSPIRIS, SAPIEN TAVI) and the dominant incumbent Labcor competes against in the biological valve segment across adult and emerging transcatheter markets.
• W. L. Gore & Associates: Manufacturer of ePTFE vascular grafts (GORE-TEX) and other implantable medical devices, competing with Labcor in vascular reconstruction and patch products across global hospital channels.
• LivaNova: Global cardiovascular device company offering the Perceval sutureless biological heart valve and other cardiac surgery products, competing with Labcor in the biological valve replacement market.
• Abbott: Cardiovascular device incumbent offering tissue heart valves (Trifecta, Epic) and TAVI devices (Portico/Navitor), directly competing with Labcor in biological valve replacement.

Emerging players

• Admedus: Australian-listed medical device company developing tissue-engineered heart valves and vascular grafts using proprietary ADAPT technology, comparable to Labcor's L-Hydro-based tissue engineering approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/labcor_
• LinkedInlinkedin.com/company/labcor-bioproteses
• Instagraminstagram.com/labcorbioproteses
• Facebookfacebook.com/profile.php

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Labcor